Clinical Trials Directory

Trials / Unknown

UnknownNCT04268563

Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients

Comparing the Therapeutic Effect of Sitagliptin/Metformin and Metformin on Biochemical Factors and Expression of GDF-9 and BMP-15 Genes in Patients With Classic PCOS Undergoing Intra-cytoplasmic Sperm Injection (ICSI)

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
Female
Age
25 Years – 35 Years
Healthy volunteers
Not accepted

Summary

Investigators will evaluate and compare the efficacy of Sitagliptin/Metformin to metformin and sitagliptin on gdf9 and bmp15 gene expression on PCOS patients undergoing intracytoplasmic sperm injection(ICSI).

Detailed description

This study was conducted in Infertility clinic of Mahdiyeh Educational Hospital, Tehran. Patients in the four groups receive the drug 2 months before the start of the ovulation cycle, and treatment will continue until the day of the oocyte aspiration. The drug provide by midwife to patients and both patient and physician blind to the treatment regimen. The participants randomly divide into four groups.The ovulation induction stimulate with GnRh antagonist.

Conditions

Interventions

TypeNameDescription
DRUGplaceboOral rehydration solution
DRUGmetforminmetformin tablet
DRUGSitagliptinSitagliptin tablet
DRUGSitagliptin/metforminSitagliptin/metformin tablet

Timeline

Start date
2020-01-10
Primary completion
2021-07-19
Completion
2021-07-30
First posted
2020-02-13
Last updated
2021-03-22

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT04268563. Inclusion in this directory is not an endorsement.